| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Dez―13 |
Eco-friendly Fenton reagents-based negative ζ potential engineering on porous carbon materials and its application on effective removal of methylene blue and SARS-CoV-2 virus by enhanced electrostatic interaction |
Keyang Li, Bo Sun, Zhiqing Xu, Mengda Hou, Chun Li, Quanquan Pan, et al. (+6) Jianning Gan, Yilun Huang, Qiang Ding, Ming Zhao, Daming Zhuang, Qianming Gong |
| 2 |
[GO] |
2024―Nov―06 |
Synthesis of naphthoquinone-fused enediyne sugar polysulfates for nanomolar inhibition of coronavirus |
Xiaohua Huang, Jing Miao, Hongyu Zheng, Lingjing Mao, Zhe Ding, Xinyu Yu, et al. (+3) Jingtao Xu, Jiaming Lan, Aiguo Hu |
| 3 |
[GO] |
2024―Nov―06 |
Computational Discovery of SARS-CoV-2 Main Protease Inhibitors Via a Virtual Screening, Molecular Docking, Molecular Dynamics and MM/PBSA Calculations-Driven Approach |
Sheng-Qi Huang, Yan-Jun Zhang, Zhonghua Wang, Fei Xiong |
| 4 |
[GO] |
2024―Okt―01 |
Synthesis of acyclic analogues of adenosine sulfonamides and their activity against RNA cap guanine N7-methyltransferase of SARS-CoV-2 |
Rostom Ahmed-Belkacem, Adrien Delpal, Bruno Canard, Jean-Jacques Vasseur, Etienne DECROLY, Françoise Debart |
| 5 |
[GO] |
2024―Aug―14 |
Design and synthesis of copper(ii) and nickel(ii) complexes as potential inhibitors against SARS-CoV-2 viral RNA binding protein and Omicron RBD protein |
Reyaz Ahmad, Mukesh Choudhary |
| 6 |
[GO] |
2024―Jul―30 |
Quinoxaline Derivatives as Potent Compounds against Both 3CLpro and PLpro Enzymes of SARS-CoV-2 virus: An Insight from Experimental and Theoretical Approaches |
Nazanin Norozi Shad, Hossein Sabet-Sarvestani, vahid moghimi, Toktam Afrough, Kamahldin Haghbeen, Hossein Eshghi |
| 7 |
[GO] |
2024―Mai―04 |
Nano-Crystallites of Ruthenium(III) Violurate Complex: Synthesis, Characterization, PXRD and DFT Structural Analysis. DNA/ HSA -Binding, Antiviral Activity Against COVID-19 and Molecular Docking Study |
Abdulrahman Alhadhrami |
| 8 |
[GO] |
2024―Mai―03 |
Synthesis of Zn(ii) coordination complexes, their molecular design and docking with SARS-CoV-2 RBD protein and Omicron spike protein |
Simranjeet Singh, Mukesh Choudhary |
| 9 |
[GO] |
2024―Feb―09 |
A heparan sulfate proteoglycan-mimicking AIE fluorescent probe for SARS-CoV-2 detection |
Fang Liu, Yue Huang, Yutong Li, Yongcheng Chen, Qiao Jin, Jian Ji |
| 10 |
[GO] |
2024―Jan―12 |
A new Cu(ii) complex derived from the reaction between tris(2-aminoethyl)amine and Cu(i)-activated acetonitrile with potent anticancer activity against some cell lines and high affinity for the essential proteins of SARS-CoV-2 |
Farshid Hajibabaei, Sadegh Salehzadeh, Katayoun Derakhshandeh, Robert William Gable |
| 11 |
[GO] |
2023―Dez―18 |
Design and numerical-phase analysis of an SPR system for direct detection of SARS-CoV-2 virus in pharyngeal swab solution |
Yansheng Liu, Junpeng Deng, Xiaobo Jia, Jin Zhou, Hongli Li, Xiaohong Wang, et al. (+4) Yating Chen, zhenle qin, Zhicheng Jin, Guofu Wang |
| 12 |
[GO] |
2023―Okt―13 |
Usnic acid based thiazole-hydrazones as multi-targeting inhibitors of a wide spectrum of SARS-CoV-2 viruses |
Olga I. Yarovaya, Aleksandr S. Filimonov, Dmitriy S. Baev, Sophia S. Borisevich, Varvara Yu. Chirkova, Anna V. Zaykovskaya, et al. (+6) Ekaterina D. Mordvinova, Svetlana V. Belenkaya, Dmitriy N. Shcherbakov, Olga A. Luzina, Oleg V. Pyankov, Nariman F. Salakhutdinov |
| 13 |
[GO] |
2023―Sep―29 |
Hydrogen-bond-assisted topochemical synthesis of a multivalent zwitterionic tetramer via concomitant cross- and homo [2+2] photocycloadditions. Theoretical antiviral activity against SARS-CoV-2 |
Ana M. Escalona, Frank Heinemann, Alexander Ovidio Briceno, Ysaias Alvarado, José Paz, Carla Lossada, et al. (+3) Lenin Gozález-Paz, Robert Antonio Toro, Jose Henao |
| 14 |
[GO] |
2023―Mai―22 |
An ultrasensitive electrochemiluminescence immunosensor for SARS-CoV-2 nucleocapsid protein detection based on signal amplification strategy of DMSN@QDs |
Shasha Feng, Fubin Pei, Wei Hu, Zhiwei Liu, Bin Du, Xihui Mu, et al. (+4) Bing Liu, Qingli Hao, Wu Lei, Zhaoyang Tong |
| 15 |
[GO] |
2023―Feb―10 |
Ecofriendly aminochalcogenation of alkenes: a green alternative to obtain compounds with potential anti SARS-CoV-2 activity |
Luana Da Silva Gomes, Jose Neto, Iris Di Leo, Cecilia Gomes Barbosa, Carolina Borsoi Moraes, Lucio Freitas Junior, et al. (+3) Bruno Rizzuti, Claudio Santi, Vanessa Nascimento |
| 16 |
[GO] |
2023―Jan―05 |
New nickel(ii) Schiff base complexes as potential tools against SARS-CoV-2 Omicron target proteins: an in silico approach |
Sunil Kumar, Mukesh Choudhary |
| 17 |
[GO] |
2023―Jan―04 |
Biphenyl furanocoumarin compounds inhibit SARS-CoV-2 spike pseudovirus infection by binding ACE2 |
Yuexin Lv, Shuai Ge, Qiumei Zhu, Min Si, Cheng Wang, Huaizhen He |
| 18 |
[GO] |
2022―Nov―16 |
Emerging membrane technologies and disinfection methods for efficient removal of waterborne pathogens during COVID-19 pandemic and post-pandemic |
Shadpour Mallakpour, Elham Azadi, Chaudhery Mustansar Hussain |
| 19 |
[GO] |
2022―Okt―25 |
Tailoring the electrocatalytic activity of porous carbon with heteroatom dopants for the quantification of COVID-19 frontline medicine in pharmaceuticals and biological samples |
Narmatha Sivaraman, Vel Duraisamy, Sakkarapalayam Murugesan Senthil Kumar, R. Thangamuthu |
| 20 |
[GO] |
2022―Sep―05 |
Identification of pyridine derivative of diselenides as potent inhibitor of main protease of SARS-CoV-2 through in silico screening and biochemical evaluation |
Beena G Singh, Vishwa V. Gandhi, Prasad P Phadnis, Amit Kunwar |
| 21 |
[GO] |
2022―Jun―29 |
Development of an Actinium-225 Radioimmunoconjugate for Targeted Alpha Therapy against SARS-CoV-2 |
Roger M. Pallares, Matthew Flick, Katherine M Shield, Tyler A Bailey, Nileena Velappan, Antonietta M Lillo, Rebecca Abergel |
| 22 |
[GO] |
2022―Mai―27 |
Casiopeinas® as SARS-CoV-2 main protease (Mpro) inhibitors. A combined DFT, molecular docking and ONIOM approach |
Miguel Reina, Luis Gabriel Talavera Contreras, Yeshenia Figueroa De Paz, Lena Ruiz-Azuara, Luis Hernández Ayala |
| 23 |
[GO] |
2022―Apr―04 |
Label-Free and Reagentless Electrochemical detection of nucleocapsid protein of SARS-CoV-2: An ultrasensitive and Disposable Biosensor |
Elif Burcu Aydin, Muhammet Aydin, Mustafa Kemal Sezgintürk |
| 24 |
[GO] |
2022―Feb―22 |
Synthesis and characterization of novel copper(ii) complexes as potential drug candidates against SARS-CoV-2 main protease |
Sunil Kumar, Mukesh Choudhary |
| 25 |
[GO] |
2021―Dez―22 |
A graphene-printed paper electrode for determination of H2O2 in municipal wastewater during the COVID-19 pandemic |
Tushar Kant, Kamlesh Shrivas, Indrapal Karbhal, Sanjay Yadav, Sushama Sahu, Yugal Kishor Mahipal, Vellaichamy Ganesan |
| 26 |
[GO] |
2021―Dez―21 |
Quantum Design of Transition Metals Decorated on Boron Phosphide Inorganic Nanocluster for Favipiravir Adsorption: A Possible Treatment for Covid-19 |
Muhammad Ramzan Saeed Ashraf Janjua |
| 27 |
[GO] |
2021―Sep―10 |
Adsorption of chloroquine and hydroxychloroquine as potential drugs for SARS-CoV-2 infection on BC3 nanosheets: a DFT study |
Rezvan Rahimi, Mohammad Solimannejad, Mohadeseh Farghadani |
| 28 |
[GO] |
2021―Sep―10 |
Design and Synthesis of De Novo Boomerang Shaped Molecules and their In Silico & SERS-based Interactions with SARS-CoV-2 Spike Protein and ACE2 |
Amrutham Linet, Manu M Joseph, Haritha Mambatta, Shamna k, Sunil varughese, Parukuttyamma Sujatha Devi, et al. (+3) CH Suresch, Kaustabh Maiti, Ishita Neogi |
| 29 |
[GO] |
2021―Jul―24 |
Proposing high-affinity inhibitors from Glycyrrhiza glabra L. against SARS-CoV-2 infection: Virtual screening and computational analysis |
Mina Maddah, Roodabeh Bahramsoltani, Nafiseh Hoseini Yekta, Roja Rahimi, Rasoul Aliabadi, Mahdi Pourfath |
| 30 |
[GO] |
2021―Jul―21 |
Modeling the Interaction of SARS-CoV-2 Binding to the ACE2 Receptor by Molecular Theory of Solvation |
Alexander E Kobryn, Yutaka Maruyama, Carlos A. Velázquez-Martínez, Norio Yoshida, Sergey Gusarov |
| 31 |
[GO] |
2021―Mai―17 |
The computational approach of designing novel SARS-CoV-2 Mpro inhibitors: combined QSAR, molecular docking, and molecular dynamics simulation techniques |
Jianbo Tong, Ding Luo, Haiyin Xu, Shuai Bian, Xing Zhang, Xuechun Xiao, Jie Wang |
| 32 |
[GO] |
2021―Apr―21 |
Fight against COVID-19 pandemic with the help of carbon-based nanomaterials |
Shadpour Mallakpour, Elham Azadi, Chaudhery Mustansar Hussain |
| 33 |
[GO] |
2021―Apr―14 |
Computational analysis of Macrolides as SARS-CoV-2 Main Protease Inhibitors: A Pattern Recognition Study Based on Molecular Topology and validated by Molecular Docking |
Riccardo Zanni, Maria Galvez-Llompart, Jorge Galvez |
| 34 |
[GO] |
2021―Apr―01 |
Toward an efficient and eco-friendly route for the synthesis of dimeric 2,4-diacetyl phloroglucinol and its potential as a SARS-CoV-2 main protease antagonist insight from in silico studies |
Triana Kusumaningsih, Wahyu Eko Prasetyo, Fajar Rakhman Rakhman Wibowo, Maulidan Firdaus |
| 35 |
[GO] |
2021―Mrz―03 |
The latest strategists for the fight against COVID-19 pandemic: The role of metals and metal oxides nanoparticles |
Shadpour Mallakpour, Elham Azadi, Chaudhery Mustansar Hussain |
| 36 |
[GO] |
2020―Dez―09 |
Nitric oxide as a therapeutic option for COVID-19 treatment: a concise perspective |
Jan Mohammad Mir, R. C. Maurya |
| 37 |
[GO] |
2020―Nov―18 |
Transition metal complexes as the potential tools against SARS-CoV-2: In silico approach |
Maynak Pal, Dulal Musib, Mithun Roy |
| 38 |
[GO] |
2020―Okt―12 |
Two Antioxidant 2,5-Disubstituted-1,3,4-oxadiazoles (CoViTris2020 and ChloViD2020): Striking Successful Repurposing against COVID-19 as the First Potent Multitarget Anti-SARS-CoV-2 Drugs |
Amgad M. Rabie |
| 39 |
[GO] |
2020―Aug―31 |
Molecular docking reveals the potential of Cleome amblyocarpa isolated compounds to inhibit COVID-19 virus main protease |
Ahmed Zaki, Ahmed A. Al-Karmalawy, Yasser El-Amier, Ahmed Ashour |
| 40 |
[GO] |
2020―Jul―01 |
GS-5734: FDA potentially approved drug against SARS-Cov-2 |
Zhonglei Wang, Liyan Yang |
| 41 |
[GO] |
2020―Mai―08 |
Whole Genome Sequence Analysis and Homology Modelling of Main Protease and Non-Structural Protein 3 of the SARS-CoV-2 reveals an Aza-Peptide and a Lead Inhibitor with Possible Antiviral Properties |
Arun K Shankar, Divya Bhanu, Anjani Alluri, Samriddhi Gupta |
